No-Observed-Adverse-Effect Level
"No-Observed-Adverse-Effect Level" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The highest dosage administered that does not produce toxic effects.
| Descriptor ID |
D019055
|
| MeSH Number(s) |
E05.940.600 G07.690.936.750
|
| Concept/Terms |
No-Observed-Adverse-Effect Level- No-Observed-Adverse-Effect Level
- Level, No-Observed-Adverse-Effect
- Levels, No-Observed-Adverse-Effect
- No Observed Adverse Effect Level
- No-Observed-Adverse-Effect Levels
- NOAEL
No-Observed-Effect Level- No-Observed-Effect Level
- Level, No-Observed-Effect
- Levels, No-Observed-Effect
- No Observed Effect Level
- No-Observed-Effect Levels
Acceptable Daily Intake- Acceptable Daily Intake
- Acceptable Daily Intakes
- Daily Intake, Acceptable
- Daily Intakes, Acceptable
- Intake, Acceptable Daily
- Intakes, Acceptable Daily
- Tolerable Daily Intake
- Daily Intake, Tolerable
- Daily Intakes, Tolerable
- Intake, Tolerable Daily
- Intakes, Tolerable Daily
- Tolerable Daily Intakes
|
Below are MeSH descriptors whose meaning is more general than "No-Observed-Adverse-Effect Level".
Below are MeSH descriptors whose meaning is more specific than "No-Observed-Adverse-Effect Level".
This graph shows the total number of publications written about "No-Observed-Adverse-Effect Level" by people in this website by year, and whether "No-Observed-Adverse-Effect Level" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "No-Observed-Adverse-Effect Level" by people in Profiles.
-
Chang DF, Prajna NV, Szczotka-Flynn LB, Benetz BA, Lass JH, O'Brien RC, Menegay HJ, Gardner S, Shekar M, Rajendrababu S, Rhee DJ. Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification. J Cataract Refract Surg. 2020 Mar; 46(3):355-359.
-
Danaher M, Shanahan C, Butler F, Evans R, O'Sullivan D, Glynn D, Camon T, Lawlor P, O'Keeffe M. Risk-based approach to developing a national residue sampling plan for testing under European Union regulation for veterinary medicinal products and coccidiostat feed additives in domestic animal production. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Jul; 33(7):1155-65.
-
Brent RL. Lauriston S. Taylor lecture: fifty years of scientific research: the importance of scholarship and the influence of politics and controversy. Health Phys. 2007 Nov; 93(5):348-79.
-
Brent RL, Weitzman M. The current state of knowledge about the effects, risks, and science of children's environmental exposures. Pediatrics. 2004 Apr; 113(4 Suppl):1158-66.
-
Brent RL, Tanski S, Weitzman M. A pediatric perspective on the unique vulnerability and resilience of the embryo and the child to environmental toxicants: the importance of rigorous research concerning age and agent. Pediatrics. 2004 Apr; 113(4 Suppl):935-44.
-
Driscoll CD, Valentine R, Staples RE, Chromey NC, Kennedy GL. Developmental toxicity of diglyme by inhalation in the rat. Drug Chem Toxicol. 1998 May; 21(2):119-36.
-
Rickard LB, Driscoll CD, Kennedy GL, Staples RE, Valentine R. Developmental toxicity of inhaled N-methylformamide in the rat. Fundam Appl Toxicol. 1995 Dec; 28(2):167-76.